Bank Julius Baer & Co. Ltd, Zurich Logic Bio Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 22, 2022	SELL	$0.35 - $0.74 $6,807 - $14,393	-19,450 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.61 - $2.49 $11,864 - $48,430	19,450 New	19,450 $13,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.